huntermathews498772

img src="" alt="List Of Danish Biotech Companies" align="right" style="max-width:32% max-height:242px; width:auto; margin:0px 10px; height:auto;"> <h1>A List Of Danish Biotech Companies</h1> <p>If you're seeking accurate information about Danish biotech companies, consider using a service like BoldData. BoldData's database has data from the Central Business Register and Danish Chambers of Commerce. This database can help develop a successful marketing plan to promote your biotech business. BoldData's data can assist you to develop a more targeted marketing campaign.

/p> <h2>Orphazyme

/h2>

p>A biopharmaceutical company in late-stage Orphazyme is in the process of developing a new treatment for the neurodegenerative disease Niemann-Pick type C. The company has a lead drug under development, called arimoclomol. The company plans to file an application for marketing authorization to the EMA in second-half 2020.

/p> <p>The company has a long history of focusing on rare diseases. It was created by Thomas Kirkegaard and Marja Jaattela in 2010. They've focused their efforts on the storage of lysosomes in particular.

/p> <h2>Symphogen

/h2>

p>French pharmaceutical Servier has agreed that Symphogen will be purchased by Symphogen, a French biotech company Symphogen. Symphogen is a Danish biotech company that has created an antibody discovery platform to aid in cancer treatment. Servier's antibody pipeline will be strengthened by this acquisition. For the past two years, the two companies have been working together within the immuno-oncology field. The acquisition will allow Servier to fully leverage Symphogen's technology and expertise.

/p> <p>Symphogen has a strong management team that is diverse and experienced. Symphogen's CEO, Kirsten Drejer is a veteran of the industry with a record of building solid pipelines and propelling the company into a solid financial position. The company also has assets with positive clinical evidence.

/p> <h2>Galecto Biotech

/h2>

p>Galecto Biotech is a Danish biotech company that creates innovative treatments for serious illnesses. The principal product it is developing inhibits galectin-3 as a protein which is involved in a myriad of inflammatory and immune reactions. The company is currently conducting clinical trials to treat idiopathic pulmonary fibrosis. It has partnered with Bristol-Myers Squibb and has plans to conduct additional clinical trials to treat fibrotic diseases. https://blogfreely.net/sharkyear68/choosing-the-right-names-of-company-in-denmark

/p> <p>Galecto Biotech's products are based upon a research technology that targets the galectin-3 receptor. The company's product development teams are focused on developing and commercializing chemically derived therapeutic drugs however they're not limited to this. The company is also in late-stage clinical trials for galectin modulator. This could eventually lead to a cure for nasal polyposis and asthma.

/p> <h2>Novo Nordisk

/h2>

p>The biotech company has been successful in acquiring another biotech company in the U.S. in the last year, Dicerna Pharmaceuticals of Lexington. Dicerna had previously developed medicines that were based on RNA interference. This shuts down certain genes that cause diseases.

/p> <p>The company plans to invest 17 billion Danish Kroner in three new manufacturing plants and increase the capacity of an existing Kalundborg facility. These new facilities will enhance the global value chain's capacity. They will also increase the production of oral and injectable products. All new facilities will come with the latest production technology.

/p> <h2>Novozymes

/h2>

p>Novozymes is a Danish biotechnology company, is a specialist in industrial enzymes. The company has a variety of markets for its products and revenues are primarily generated in the following areas: agriculture, bio-energy and household care. Novozymes was established in 1988 and has its headquarters in Copenhagen in Denmark.

/p> <p>The Danish biotech company has a long record of success in product roll-out. Its predecessor, Nordisk Insulinlaboratorium, launched its first enzyme, trypsin in 1941. This enzyme was initially utilized for softening leather. The process of fermentation for enzyme production was also developed by the company. It developed the first enzyme for detergent production in the late 1980s, called lipolase. This enzyme increased the freshness and quality of white breads and buns.

/p> <h2>Lilly

/h2>

p>Denmark is home to a variety of top biotech companies. These companies employ cutting-edge biotechnology to fight cancer, create vaccines, and develop other medical solutions. Oncology Venture ApS specializes in research and development in the area of cancer. Other notable companies include AquaGreen, a Danish biotech engineering company, and STipe Therapeutics, which harnesses the innate immune system to fight cancer. Acesion Pharma, a Danish biotech company, is developing treatments for atrial fibrillation.

/p> <p>The medical technology and biotechnology industries have a long tradition in Denmark and Sweden. They are among the five leading pharmaceutical exporters worldwide. Denmark also has one of the highest per-capita R&D expenditures in the European pharmaceutical industry, second only to Switzerland. Additionally, 60 percent of the pharmaceutical activities in Scandinavia are concentrated in the Medicon Valley, a Danish-Swedish cross-border cluster.

/p> <h2>Innovent

/h2>

p>Innovent Biotech recently purchased exclusive rights to Eli Lilly's cancer medicines in China. Innovent will be able control the pricing, marketing, and distribution of these drugs. Both companies will collaborate on the development and distribution of treatments for the most difficult to meet medical needs, like eczema or cancer.

/p> <p>Innovent has a large pipeline, with 16 potential products. Seven of them are currently under development for clinical trials. The company also collaborated with Eli Lilly to develop three Chinese cancer treatments. Another Danish biotech company, Ascentage, has partnered with Oriza Ventures and the Chinese state-backed SDIC Fund Management.

/p> <iframe height="282" allowfullscreen="true" frameborder="0" src="https://www.youtube.com/embed/ccGs550TSjk" width="505" style="margin:0px auto; display: block;"></iframe>